Get all your news in one place.
100's of premium titles.
One app.
Start reading
The Independent UK
The Independent UK
World
Ella Pickover

Donanemab: What is the new Alzheimer’s drug rejected for use on the NHS

A daughter looking after her mother who is suffering from Alzheimer’s -

The drug Donanemab has been found to slow the progression of Alzheimer’s disease.

Despite this is has been rejected for widespread use in the health service in England after the health spending watchdog said it “does not currently demonstrate value for the NHS”.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.